In the KO-cell groups, the tumour was engrafted (Fig. 2a and b), but the tumourigenicity here was markedly diminished as compared with that of the WT or mock control group, which suggested that ERO1α deficiency reduced the tumourigenicity of the cancer cells. The gene discussed is ERO1A; the disease is cancer.